Cargando…

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition

PURPOSE: Fibroblast growth factor receptor 4 (FGFR4) plays an important role in cancer progression during tumor proliferation, invasion, and metastasis. This study evaluated the prognostic role of FGFR4 polymorphism in patients with resected colon cancer, including the underlying mechanism. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Sang Hee, Hong, Chang Soo, Kim, Hee Nam, Shin, Min Ho, Kim, Ka Rham, Shim, Hyun Jeong, Hwang, Jun Eul, Bae, Woo Kyun, Chung, Ik Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512371/ https://www.ncbi.nlm.nih.gov/pubmed/27857023 http://dx.doi.org/10.4143/crt.2016.457

Ejemplares similares

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2021)

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
por: Streit, S, et al.
Publicado: (2006)

FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
por: Frullanti, Elisa, et al.
Publicado: (2010)

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
por: Matakidou, A, et al.
Publicado: (2007)

Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility
por: Chou, Chia-Hsuan, et al.
Publicado: (2017)

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis
por: Xiong, Si-Wei, et al.
Publicado: (2017)

FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma
por: Akdeniz Odemis, Demet, et al.
Publicado: (2020)

A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting
por: Kim, Ka-Rham, et al.
Publicado: (2015)

FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition
por: Ye, Yanwei, et al.
Publicado: (2020)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022)

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

FGFR4 Gly(388)Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
por: Xu, Bin, et al.
Publicado: (2011)

Intravenous KITENIN shRNA Injection Suppresses Hepatic Metastasis and Recurrence of Colon Cancer in an Orthotopic Mouse Model
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

A rare case of highly differentiated follicular carcinoma in ovary with FGFR4 Gly388Arg polymorphism: a case report and literature review
por: Bao, Yi-Ting, et al.
Publicado: (2022)

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
por: Jézéquel, P, et al.
Publicado: (2004)

The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma
por: Zlatkutė, Eglė, et al.
Publicado: (2017)

Adrenal Corticomedullary Mixed Tumor Associated With the FGFR4-G388R Variant
por: Kanzawa, Maki, et al.
Publicado: (2020)

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer
por: Peng, Tao, et al.
Publicado: (2021)

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
por: Hwang, Jun-Eul, et al.
Publicado: (2010)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
por: Kim, Young Il, et al.
Publicado: (2010)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas
por: Wimmer, Eva, et al.
Publicado: (2019)

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling
por: Cho, Sang-Hee, et al.
Publicado: (2021)

Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012)

Suppressive Effect of 19-nor-1α-25-Dihydroxyvitamin D2 on Gastric Cancer Cells and Peritoneal Metastasis Model
por: Park, Mi Ra, et al.
Publicado: (2012)

A novel NPR2 mutation (p.Arg388Gln) in a patient with acromesomelic dysplasia, type Maroteaux
por: Amano, Naoko, et al.
Publicado: (2020)

The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis
por: Hwang, Jun Eul, et al.
Publicado: (2017)

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy
por: Shim, Hyun-Jeong, et al.
Publicado: (2020)

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Kim, Hyeon-Jong, et al.
Publicado: (2023)

Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer
por: Hong, Chang‐Soo, et al.
Publicado: (2020)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
por: Kim, Dae-Eun, et al.
Publicado: (2013)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
por: Tateno, Toru, et al.
Publicado: (2011)

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis
por: Sun, Eun-Gene, et al.
Publicado: (2023)

388. New Observations in Coccidioidomycosis Serology
por: Mchardy, Ian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mm1j305b9c08q1b86mchdq06bn